kw.\*:("Resistencia al tratamiento terapeútico")
Results 1 to 25 of 5059
Selection :
The resistance also comes from withinCAETANO, R.British journal of addiction (1980). 1988, Vol 83, Num 1, pp 39-41, issn 0952-0481Article
Pouvoir métastatique et chimio-résistance = Metastasis and drug resistanceVENNIN, P; CAPPELAERE, P.Lille médical (1987). 1989, Vol 29, Num 1, pp 45-49, 5 p.Article
An international perspective on antimicrobial resistanceWIEDEMANN, B.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.19S-6A, issn 0002-9343, -20SConference Paper
Working through resistances of intrapsychic and environmental originGILL, H. S.International journal of psycho-analysis. 1988, Vol 69, Num 4, pp 535-550, issn 0020-7578Article
Multiple drug resistanceMITSCHER, Lester A.Medicinal research reviews (Print). 1999, Vol 19, Num 6, issn 0198-6325, 124 p.Conference Proceedings
Microbial resistance to drug therapy : A reviewCOHEN, F. L; TARTASKY, D.American journal of infection control. 1997, Vol 25, Num 1, pp 51-64, issn 0196-6553Article
Antimicrobial drug resistanceWAIYAKI, P. G.East African medical journal. 1997, Vol 74, Num 3, issn 0012-835X, 85 p.Serial Issue
Tumor drug-resistance : a challenge to therapists and biologistsMANSOURI, A; HENLE, K. J; NAGLE, W. A et al.The American journal of the medical sciences. 1994, Vol 307, Num 6, pp 438-444, issn 0002-9629Article
Evolution de la chimiorésistance du paludisme importé en France en 1990LE BRAS, J; RABENJARSON, E; RINGWALD, P et al.Médecine et hygiène. 1991, Vol 49, Num 1900, pp 2314-2320, issn 0025-6749, 4 p.Conference Paper
Insuffisance d'une cure d'halofantrine sur un paludisme à Plasmodium falciparum chloroquinorésistant contracté en Sierra Leone = Ineffectiveness of halofantrine against chloroquine-resistant Plasmodium falciparum malaria contracted in Sierra LeoneGAY, F; BUSTOS, D; CAUMES, E et al.Annales de médecine interne (Paris). 1990, Vol 141, Num 5, pp 493-494, issn 0003-410XArticle
Plasma volume in resistant hypertension: guide to pathophysiology and therapyGRAVES, J. W; BLOOMFIELD, R. L; BUCKALEW, V. M et al.The American journal of the medical sciences. 1989, Vol 298, Num 6, pp 361-365, issn 0002-9629, 5 p.Article
Violence in treatment resistant psychotic inpatientsEHMANN, Thomas S; SMITH, Geoffrey N; YAMAMOTO, Aiko et al.The Journal of nervous and mental disease. 2001, Vol 189, Num 10, pp 716-721, issn 0022-3018Article
Sélection de résistance sous la pression des nouveaux antibiotiques = Resistance selection under new antibiotherapy pressurePECHERE, J. C.Réanimation urgences (Paris). 1999, Vol 8, pp 22s-26s, issn 1164-6756, SUP1Conference Paper
L'efflux actif : Un phénomène de résistance bactérienne inquiétant = Bacterial resistance by active effluxKÖHLER, T; PECHERE, J. C; PLESIAT, P et al.La Presse médicale (1983). 1997, Vol 26, Num 4, pp 173-177, issn 0755-4982Article
Poor response to erythropoietin : practical guidelines on investigation and managementMACDOUGALL, I. C.Nephrology, dialysis, transplantation (Print). 1995, Vol 10, Num 5, pp 607-614, issn 0931-0509Conference Paper
Les dépressions résistantes = Treatment resistant depressionDUFOUR, H.Médecine et hygiène. 1995, Vol 53, Num 2086, pp 1882-1886, issn 0025-6749, 3 p.Article
Multiple drug resistance in cancer therapySCHNEIDER, E; COWAN, K. H.Medical journal of Australia. 1994, Vol 160, Num 6, pp 371-373, issn 0025-729XArticle
Hypoxia and drug resistanceTEICHER, B. A.Cancer metastasis reviews. 1994, Vol 13, Num 2, pp 139-168, issn 0167-7659Article
Chemotherapeutic failure : resistance or insensitivity ?BRAVERMAN, A. S.Annals of internal medicine. 1993, Vol 118, Num 8, pp 630-632, issn 0003-4819Article
Clinical and blood bank factors in the management of platelet refractoriness and alloimmunizationFRIEDBERG, R. C; DONNELLY, S. F; BOYD, J. C et al.Blood. 1993, Vol 81, Num 12, pp 3428-3434, issn 0006-4971Article
Regression und Anti-Regression = Regression and anti-regressionSANDLER, J; SANDLER, A.-M.Forum der Psychoanalyse. 1993, Vol 9, Num 4, pp 283-292, issn 0178-7667Article
Optimal control of tumor size used to maximize survival time when cells are resistant to chemotherapyMARTIN, R. B; FISHER, M. E; MINCHIN, R. F et al.Mathematical biosciences. 1992, Vol 110, Num 2, pp 201-219, issn 0025-5564Article
Comment les cancers échappent-ils à la chimiothérapie ? = Resistance of cancer cells to chemotherapy and reversionPOUPON, M.-F.Pathologie et biologie. 1992, Vol 40, Num 9BIS, pp 923-927, issn 0369-8114Article
Infection urinaire en gynécologie-obstétrique : résistance aux bêtalactamines et antibiothérapie préalable = Urinary tract infection in gynecology-obstetrics: beta lactam antibiotics resistance and previous antibiotic treatmentBORDERON, E; TESCHER, M; DU ROUCHET, E et al.Pathologie et biologie. 1990, Vol 38, Num 5 bis, pp 538-542, issn 0369-8114Article
Concurrence of axis I and axis II illness in treatment-resistant hospitalized patientsMARCUS, E; BRADLEY, S.The Psychiatric clinics of North America. 1987, Vol 10, Num 2, pp 177-184, issn 0193-953XArticle